Gene Therapy Rescues Retinal Degeneration in Receptor Expression-Enhancing Protein 6 Mutant Mice
- 18 March 2019
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 30 (3) , 302-315
Abstract
Hereditary retinal dystrophy is clinically defined as a broad group of chronic and progressive disorders that affect visual function by causing photoreceptor degeneration. Previously, we identified mutations in the gene encoding receptor expression-enhancing protein 6 (REEP6), in individuals with autosomal recessive retinitis pigmentosa (RP), the most common form of inherited retinal dystrophy. One individual was molecularly diagnosed with biallelic REEP6 mutations, a missense mutation over a frameshift mutation. In this study, we generated Reep6 compound heterozygous mice, Reep6 L135P/− , which mimic the patient genotype and recapitulate the early-onset retinal degeneration phenotypes observed in the individual with RP. To determine the feasibility of rescuing the Reep6 mutant phenotype via gene replacement therapy, we delivered Reep6.1 , the mouse retina-specific isoform of REEP6 , to photoreceptors of Reep6 mutant mice on postnatal day 20. Evaluation of the therapeutic effects 2 months posttreatment showed improvements in the photoresponse as well as preservation of photoreceptor cells. Importantly, guanylyl cyclase 1 (GC1) expression was also restored to the outer segment after treatment. Furthermore, rAAV8- Reep6.1 single treatment in Reep6 mutant mice 1 year postinjection showed significant improvements in retinal function and morphology, suggesting that the treatment is effective even after a prolonged period. Findings from this study show that gene replacement therapy in the retina with rAAV overexpressing Reep6 is effective, preserving photoreceptor function in Reep6 mutant mice. These findings provide evidence that rAAV8-based gene therapy can prolong survival of photoreceptors in vivo and can be potentially used as a therapeutic modality for treatment of patients with RP.Keywords
This publication has 49 references indexed in Scilit:
- Arl3 and RP2 regulate the trafficking of ciliary tip kinesinsHuman Molecular Genetics, 2017
- REEP6 deficiency leads to retinal degeneration through disruption of ER homeostasis and protein traffickingHuman Molecular Genetics, 2017
- AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout miceMolecular Therapy - Methods & Clinical Development, 2015
- RD3 gene delivery restores guanylate cyclase localization and rescues photoreceptors in the Rd3 mouse model of Leber congenital amaurosis 12Human Molecular Genetics, 2013
- The cell stress machinery and retinal degenerationFEBS Letters, 2013
- Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV VectorsPLOS ONE, 2013
- Dawn of ocular gene therapy: implications for molecular diagnosis in retinal diseaseScience China Life Sciences, 2013
- ER stress in retinal degeneration: a target for rational therapy?Trends in Molecular Medicine, 2011
- Endoplasmic reticulum stress is activated in light‐induced retinal degenerationJournal of Neuroscience Research, 2007
- A Class of Membrane Proteins Shaping the Tubular Endoplasmic ReticulumCell, 2006